Document Detail

FemCap with removal strap: ease of removal, safety and acceptability.
MedLine Citation:
PMID:  16371297     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: FemCap is a silicone-rubber barrier contraceptive approved for marketing in the United States. To address reported problems with removal and dislodgment, the device's developer added a strap to the device and increased the height of the brim. This trial assessed whether the new design reduced removal difficulties and had any effects on dislodgment, genital pain/discomfort, safety, and acceptability. METHODS: Women used the strapped device for 8 weeks with follow-up visits at 2 and 8 weeks. Outcome measures were obtained through diary cards, questionnaires, and naked eye examination. Data from these 120 women were compared with data from 419 women who used the unstrapped FemCap in a previous contraceptive effectiveness study. RESULTS: The strapped device was not significantly easier for users to remove than the unstrapped device. Similar odds of dislodgment and cervical/vaginal irritation were seen with the two devices. Both female and male participants were significantly more likely to report pain/discomfort with use of the strapped device. Female users of the strapped device were significantly more likely to say they disliked their device. In six weeks, two pregnancies were observed, but pregnancy was not an endpoint in the study and no conclusions should be drawn regarding pregnancy rates. CONCLUSIONS: The modifications to the FemCap did not significantly improve the ease of device removal and appears to have resulted in significantly more female and male partner pain/discomfort and decreased acceptability, compared with the unstrapped device.
Christine K Mauck; Debra H Weiner; Mitchell D Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Susan A Ballagh; Deborah M Henry; Marianne M Callahan
Related Documents :
1152777 - Factors influencing conception in women seeking termination of pregnancy. a pilot study...
4018277 - Absence of chorionic gonadotropin in sera of women who use intrauterine devices.
8435997 - The safety and efficacy issues of progestin-only oral contraceptives--an epidemiologic ...
7308517 - Concentrations of copper in human secretions and weight of the copper wire during the 4...
21353977 - Do religious restrictions influence ectopic pregnancy management? a national qualitativ...
12459827 - Modern concept on the role of phagocytes in the pathogenesis of complications during pr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2005-10-19
Journal Detail:
Title:  Contraception     Volume:  73     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-22     Completed Date:  2006-05-04     Revised Date:  2010-09-20    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  United States    
Other Details:
Languages:  eng     Pagination:  59-64     Citation Subset:  IM    
CONRAD, Eastern Virginia Medical School, Arlington, VA 22209, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contraceptive Devices, Female* / adverse effects
Equipment Design
Patient Satisfaction
Sexual Partners
Grant Support
M01 RR000056-390788/RR/NCRR NIH HHS; M01 RR000056-400788/RR/NCRR NIH HHS; M01 RR000056-420788/RR/NCRR NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of a subdermal levonorgestrel contraceptive implant (Norplant) on serum cholesterol, triglyc...
Next Document:  Acceptability of a home monitor used to aid in conception: psychosocial factors and couple dynamics.